Serum and urinary biomarkers in acute kidney transplant rejection

Research output: Contribution to journalArticle

Abstract

Background: Acute rejection (AR) is a common medical problem among kidney transplant recipients, which may cause a significant impact on patients' and allografts' survival. Kidney allograft biopsy remains the "gold standard" for assessing the cause of kidney transplant dysfunction. However, there are limitations for the allograft biopsy; these include the risk of bleeding, injury to the adjacent organs, and the possibility of sampling error leading to misdiagnosis. Methods: We conducted a comprehensive review of the literature and main published data that discussed the most relevant serum and urine biomarkers in acute allograft dysfunction, along with their clinical significance. Results: There have been significant discoveries of several important biomarkers that correlated with biopsy findings, clinical outcomes and possibly graft survival. Proteomic and genomic have been utilized in this area with some success, along with a growing discoveries of cytokines surrogate makers. Summary: The discovery of surrogate biomarkers in kidney transplantation is an evolving field of crucial importance that may change the way we practice transplant nephrology in the future.

Original languageEnglish (US)
Pages (from-to)13-19
Number of pages7
JournalNephrologie et Therapeutique
Volume8
Issue number1
DOIs
StatePublished - Feb 2012

Fingerprint

Graft Rejection
Allografts
Biomarkers
Kidney
Serum
Biopsy
Transplants
Nephrology
Selection Bias
Graft Survival
Diagnostic Errors
Proteomics
Kidney Transplantation
Urine
Hemorrhage
Cytokines
Survival
Wounds and Injuries

Keywords

  • Acute rejection
  • Biomarkers
  • Kidney transplantation

ASJC Scopus subject areas

  • Nephrology

Cite this

Serum and urinary biomarkers in acute kidney transplant rejection. / Alachkar, Nada.

In: Nephrologie et Therapeutique, Vol. 8, No. 1, 02.2012, p. 13-19.

Research output: Contribution to journalArticle

@article{356f2b1ad52047859faf4aa0f0d050e0,
title = "Serum and urinary biomarkers in acute kidney transplant rejection",
abstract = "Background: Acute rejection (AR) is a common medical problem among kidney transplant recipients, which may cause a significant impact on patients' and allografts' survival. Kidney allograft biopsy remains the {"}gold standard{"} for assessing the cause of kidney transplant dysfunction. However, there are limitations for the allograft biopsy; these include the risk of bleeding, injury to the adjacent organs, and the possibility of sampling error leading to misdiagnosis. Methods: We conducted a comprehensive review of the literature and main published data that discussed the most relevant serum and urine biomarkers in acute allograft dysfunction, along with their clinical significance. Results: There have been significant discoveries of several important biomarkers that correlated with biopsy findings, clinical outcomes and possibly graft survival. Proteomic and genomic have been utilized in this area with some success, along with a growing discoveries of cytokines surrogate makers. Summary: The discovery of surrogate biomarkers in kidney transplantation is an evolving field of crucial importance that may change the way we practice transplant nephrology in the future.",
keywords = "Acute rejection, Biomarkers, Kidney transplantation",
author = "Nada Alachkar",
year = "2012",
month = "2",
doi = "10.1016/j.nephro.2011.07.409",
language = "English (US)",
volume = "8",
pages = "13--19",
journal = "Nephrologie et Therapeutique",
issn = "1769-7255",
publisher = "Elsevier Masson",
number = "1",

}

TY - JOUR

T1 - Serum and urinary biomarkers in acute kidney transplant rejection

AU - Alachkar, Nada

PY - 2012/2

Y1 - 2012/2

N2 - Background: Acute rejection (AR) is a common medical problem among kidney transplant recipients, which may cause a significant impact on patients' and allografts' survival. Kidney allograft biopsy remains the "gold standard" for assessing the cause of kidney transplant dysfunction. However, there are limitations for the allograft biopsy; these include the risk of bleeding, injury to the adjacent organs, and the possibility of sampling error leading to misdiagnosis. Methods: We conducted a comprehensive review of the literature and main published data that discussed the most relevant serum and urine biomarkers in acute allograft dysfunction, along with their clinical significance. Results: There have been significant discoveries of several important biomarkers that correlated with biopsy findings, clinical outcomes and possibly graft survival. Proteomic and genomic have been utilized in this area with some success, along with a growing discoveries of cytokines surrogate makers. Summary: The discovery of surrogate biomarkers in kidney transplantation is an evolving field of crucial importance that may change the way we practice transplant nephrology in the future.

AB - Background: Acute rejection (AR) is a common medical problem among kidney transplant recipients, which may cause a significant impact on patients' and allografts' survival. Kidney allograft biopsy remains the "gold standard" for assessing the cause of kidney transplant dysfunction. However, there are limitations for the allograft biopsy; these include the risk of bleeding, injury to the adjacent organs, and the possibility of sampling error leading to misdiagnosis. Methods: We conducted a comprehensive review of the literature and main published data that discussed the most relevant serum and urine biomarkers in acute allograft dysfunction, along with their clinical significance. Results: There have been significant discoveries of several important biomarkers that correlated with biopsy findings, clinical outcomes and possibly graft survival. Proteomic and genomic have been utilized in this area with some success, along with a growing discoveries of cytokines surrogate makers. Summary: The discovery of surrogate biomarkers in kidney transplantation is an evolving field of crucial importance that may change the way we practice transplant nephrology in the future.

KW - Acute rejection

KW - Biomarkers

KW - Kidney transplantation

UR - http://www.scopus.com/inward/record.url?scp=84857233115&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857233115&partnerID=8YFLogxK

U2 - 10.1016/j.nephro.2011.07.409

DO - 10.1016/j.nephro.2011.07.409

M3 - Article

C2 - 22018843

AN - SCOPUS:84857233115

VL - 8

SP - 13

EP - 19

JO - Nephrologie et Therapeutique

JF - Nephrologie et Therapeutique

SN - 1769-7255

IS - 1

ER -